接受直接作用抗病毒（DAA）药物治疗的患者的免疫反应和隐性HCV基因型4的患病率：一项横断面研究

{"title":"接受直接作用抗病毒（DAA）药物治疗的患者的免疫反应和隐性HCV基因型4的患病率：一项横断面研究","authors":"M. El-Ansary","doi":"10.30699/ijmm.17.2.211","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":14580,"journal":{"name":"Iranian Journal of Medical Microbiology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Immunological Response and Prevalence of Occult HCV Genotype 4 Among Patients Receiving Direct-Acting Antiviral (DAA) Drugs: A Cross-Sectional Study\",\"authors\":\"M. El-Ansary\",\"doi\":\"10.30699/ijmm.17.2.211\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":14580,\"journal\":{\"name\":\"Iranian Journal of Medical Microbiology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Iranian Journal of Medical Microbiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.30699/ijmm.17.2.211\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Medical Microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30699/ijmm.17.2.211","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}